Drug class
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
11 drugs the FDA files under Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor, and that we can price. Drugs in one class are not interchangeable — they share a mechanism, not a dose or a set of side effects — but the price gap between them is often large, and it is a reasonable thing to raise with a prescriber.
- 24 HR nevirapine 400 MG Extended Release Oral TabletHuman Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
- doravirine 100 MG / lamivudine 300 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet [Delstrigo]Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
- doravirine 100 MG Oral Tablet [Pifeltro]Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
- efavirenz 200 MG Oral CapsuleHuman Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
- efavirenz 400 MG / lamivudine 300 MG / tenofovir disoproxil fumarate 300 MG Oral TabletHuman Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
- efavirenz 50 MG Oral CapsuleHuman Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
- efavirenz 600 MG / emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral TabletHuman Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
- efavirenz 600 MG Oral TabletHuman Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
- etravirine 100 MG Oral TabletHuman Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
- etravirine 200 MG Oral TabletHuman Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
- nevirapine 200 MG Oral TabletHuman Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor